NPI: 1407270804 · ANAHEIM, CA 92802 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/06/2014
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/06/2014 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,268 | $1.45M |
| 2019 | 28,535 | $1.48M |
| 2020 | 38,272 | $1.72M |
| 2021 | 38,025 | $1.86M |
| 2022 | 29,123 | $1.81M |
| 2023 | 16,944 | $2.43M |
| 2024 | 6,515 | $1.41M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 71,886 | 5,692 | $10.81M |
| A4657 | Syringe, with or without needle, each | 2,560 | 1,741 | $836K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,696 | 943 | $147K |
| J1270 | Injection, doxercalciferol, 1 mcg | 31,041 | 2,632 | $126K |
| 0250 | 2,879 | 421 | $120K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 45,678 | 3,220 | $59K |
| J1756 | Injection, iron sucrose, 1 mg | 13,232 | 3,152 | $57K |
| 82728 | 1,068 | 865 | $7K | |
| 90674 | 167 | 160 | $4K | |
| 90747 | 43 | 40 | $3K | |
| 90662 | 66 | 65 | $2K | |
| G0008 | Administration of influenza virus vaccine | 52 | 52 | $2K |
| 82108 | 144 | 118 | $795.95 | |
| 90661 | 20 | 20 | $600.57 | |
| 83970 | 1,007 | 837 | $49.83 | |
| 85041 | 1,677 | 1,343 | $13.64 | |
| 85048 | 1,667 | 1,336 | $11.55 | |
| 83550 | 1,154 | 925 | $10.83 | |
| 83540 | 1,167 | 939 | $8.99 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 301 | 214 | $0.00 |
| 0305 | 63 | 21 | $0.00 | |
| 0270 | 29 | 23 | $0.00 | |
| 0821 | 105 | 85 | $0.00 | |
| 0301 | 101 | 22 | $0.00 | |
| 0636 | 605 | 51 | $0.00 | |
| 85045 | 424 | 345 | $0.00 | |
| 0634 | 850 | 50 | $0.00 |